在2型糖尿病患者中,人们对芬诺纤维酸对脏的影响知之甚少
Alicia J Jenkins1, Rachel L O'Connell2, Andrzej S Januszewski3
1NHMRC Clinical Trials Centre, The University of Sydney, Camperdown, NSW, Australia; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
Diabetes research and clinical practice
|March 13, 2024
概括
低成本的纤维酸可为糖尿病患者提供脏保护,特别是在服务不足的地区. 需要进一步的研究来证实它在晚期病中的好处.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 糖尿病学 糖尿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病影响全球大约10%的成年人,不利地区的负担不成比例.
- 糖尿病病是一种主要的并发症,需要具有成本效益的保护策略.
- 费诺纤维酸在糖尿病试验中显示出微血管益处,但其在晚期病中的作用尚不清楚.
研究的目的:
- 为了研究 fenofibrate 在糖尿病患者,特别是晚期脏病患者的潜在脏保护作用.
- 分析FIELD子研究中的新数据,以了解纤维酸对脏结果的影响.
- 为了突出进一步临床试验的必要性,评估纤维酸在脏疾病中的作用.
主要方法:
- 从FIELD试验的特定副研究中分析数据.
- 综述现有关于纤维酸在糖尿病人群中的心血管和微血管作用的文献.
- 识别关于芬诺纤维酸在晚期功能障碍中有效性的知识差距.
主要成果:
- 介绍了关于纤维酸对脏结果相关的纤维酸效应的新替代研究数据.
- 表明现有的关于纤维酸在晚期脏疾病中的益处有限的数据.
- 突出了对全面结局数据的持续需求.
结论:
- 纤维酸盐显示出作为糖尿病患者潜在的保护剂的前景.
- 进一步的专用研究至关重要,以确定费诺纤维酸在治疗晚期糖尿病病中的有效性和安全性.
- 迫切需要更多的研究来解决这个弱势群体的知识差距.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
566
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
409
相关概念视频
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
01:36Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
01:22Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
01:17Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
199
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
199
01:15Diabetes: Management and Pharmacotherapy
281
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
281